NDC 59676-960

DOXIL

Doxorubicin Hydrochloride

DOXIL is a Intravenous Injection, Suspension, Liposomal in the Human Prescription Drug category. It is labeled and distributed by Janssen Products, Lp. The primary component is Doxorubicin Hydrochloride.

Product ID59676-960_17206b15-725c-410d-838d-ccb228c6ea2b
NDC59676-960
Product TypeHuman Prescription Drug
Proprietary NameDOXIL
Generic NameDoxorubicin Hydrochloride
Dosage FormInjection, Suspension, Liposomal
Route of AdministrationINTRAVENOUS
Marketing Start Date1995-11-17
Marketing CategoryNDA / NDA
Application NumberNDA050718
Labeler NameJanssen Products, LP
Substance NameDOXORUBICIN HYDROCHLORIDE
Active Ingredient Strength2 mg/mL
Pharm ClassesAnthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 59676-960-02

1 VIAL, SINGLE-USE in 1 CARTON (59676-960-02) > 25 mL in 1 VIAL, SINGLE-USE
Marketing Start Date1995-11-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59676-960-02 [59676096002]

DOXIL INJECTION, SUSPENSION, LIPOSOMAL
Marketing CategoryNDA
Application NumberNDA050718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1995-11-17
Marketing End Date2020-06-30

NDC 59676-960-01 [59676096001]

DOXIL INJECTION, SUSPENSION, LIPOSOMAL
Marketing CategoryNDA
Application NumberNDA050718
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1995-11-17
Marketing End Date2020-09-30

Drug Details

Active Ingredients

IngredientStrength
DOXORUBICIN HYDROCHLORIDE2 mg/mL

OpenFDA Data

SPL SET ID:21d9c619-7e94-49e2-ac41-31e9ea96554a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1790127
  • 1790131
  • 1790115
  • 1790128
  • Pharmacological Class

    • Anthracycline Topoisomerase Inhibitor [EPC]
    • Anthracyclines [CS]
    • Topoisomerase Inhibitors [MoA]

    NDC Crossover Matching brand name "DOXIL" or generic name "Doxorubicin Hydrochloride"

    NDCBrand NameGeneric Name
    59676-960DOXILDOXIL
    0338-0063DOXILDOXIL
    0338-0067DOXILDOXIL
    0069-3030Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-3031Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-3032Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-3033Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-3034Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-4004Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-4015Doxorubicin HydrochlorideDoxorubicin Hydrochloride
    0069-4026Doxorubicin HydrochlorideDoxorubicin Hydrochloride

    Trademark Results [DOXIL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DOXIL
    DOXIL
    74223789 1744235 Live/Registered
    BAXTER HEALTHCARE CORPORATION
    1991-11-21

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.